Glenmark inks licensing pact for generic Tiotropium Bromide dry powder inhaler in Western Europe

This is the second inhalation product in-licensed by Glenmark for the European market after Fluticasone/Salmeterol dry powder inhaler, the company said.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2PHiuEF
via IFTTT